Cholangitis Global H1 Clinical Trials Review Report 2017: Coverage of Disease Clinical Trials by Region, Country (G7 & E7), Phase, Trial status, End Points Status and Sponsor Type

Posted on 2017-08-25 by Mark Hub in Healthcare, Pharmaceuticals // 0 Comments

Market Research Hub

Albany, US, 2017-Aug-25 — /EPR Network/ — Market Research HUB’s clinical trial report, Cholangitis Global Clinical Trials Review, H1, 2017” provides an overview of Cholangitis clinical trials scenario. This report provides top line data relating to the clinical trials on Cholangitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Market Research HUB Clinical Trial Reports are generated using Market Research HUBs proprietary database – Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

Request Free Sample Report: http://www.marketresearchhub.com/enquiry.php?type=enquiry&repid=1297871

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Scope

– The report provides a snapshot of the global clinical trials landscape
– Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
– The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
– The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
– The Report provides enrollment trends for the past five years
– Report provides latest news for the past three months

Reasons to buy

– Assists in formulating key business strategies with regards to investment
– Helps in identifying prominent locations for conducting clinical trials which saves time and cost
– Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
– Supports understanding of trials count and enrollment trends by country in global therapeutics market
– Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
– Facilitates clinical trial assessment of the indication on a global, regional and country level

Browse Full Report With TOC: http://www.marketresearchhub.com/report/cholangitis-global-clinical-trials-review-h1-2017-report.html

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Report Guidance 5
Market Research HUB Clinical Trials Report Coverage 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Middle East and Africa 14
Clinical Trials by G7 Countries: Proportion of Cholangitis to Gastrointestinal Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Cholangitis to Gastrointestinal Clinical Trials 19
Clinical Trials by Phase in E7 Countries 20
Clinical Trials in E7 Countries by Trial Status 21
Clinical Trials by Phase 22
In Progress Trials by Phase 23
Clinical Trials by Trial Status 24
Clinical Trials by End Point Status 26
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Cholangitis Therapeutics Clinical Trials 31
Prominent Drugs 33
Latest Clinical Trials News on Cholangitis 34
May 05, 2017: GENFIT: First Patient enrolled in a Phase 2 Trial recruiting Adults with Primary Biliary Cholangitis, a Rare Liver Disease 34
Apr 19, 2017: Intercept Announces New Ocaliva (obeticholic acid) and INT-767 Data to be Presented at EASL 2017 34
Apr 19, 2017: Enanta Announces New Preclinical Data on its FXR Agonist EDP-305 for Non-Alcoholic Steatohepatitis and Primary Biliary Cholangitis at The International Liver Congress 2017 35
Clinical Trial Profile Snapshots 36
Appendix 94
Abbreviations 94
Definitions 94
Research Methodology 95
Secondary Research 95
About Market Research HUB 96
Contact Us 96
Source 96

List of Tables
Cholangitis Therapeutics, Global, Clinical Trials by Region, 2017* 7
Cholangitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 9
Cholangitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10
Cholangitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 11
Cholangitis Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 12

Continued…………

Enquire About this Report: http://www.marketresearchhub.com/enquiry.php?type=enquiry&repid=1297871

About Market Research Hub:

Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.

Matched content

Editor’s pick